Garaci

Mechanism of Action and Rationale for the Use of Biological Response Modifiers, Differentiating Agents and Nucleoside Analogues in Combination: Cytokine Synergy in Immunotherapy (J.W. Hadden et al.). Monitoring Combination Therapy Trials (J.L. Rossio et al.). Combination Chemotherapy and BRM Therapy in the Treatment of Cancer: Cancer Immunochemotherapy (G. Graziani et al.). Combination of Chronic Indomethacin and Intermittent IL2 Therapy in the Treatment of Disseminated Cancer (P.K. Lala et al.). Biological Response Modifiers and Differentiating Agents in Myelodisplastic Syndromes (A. Venditti et al.). Single and Combination Therapy with BRM’s in the Treatment of Infectious Diseases, AIDS, and Autoimmunity: AntiCytokine Therapy of Murine Candidiasis (L. Romani et al.). The Basic Research and Clinical Application of Thymopeptidin (C.X. Zheng et al.). Combination AntiHIV Therapy (T.C. Merigan). 22 additional articles. Index.